Integrated Wealth Concepts LLC Sells 170 Shares of Equifax Inc. (NYSE:EFX)

Integrated Wealth Concepts LLC decreased its holdings in Equifax Inc. (NYSE:EFX) by 3.8% in the 3rd quarter, HoldingsChannel reports. The firm owned 4,298 shares of the credit services provider’s stock after selling 170 shares during the quarter. Integrated Wealth Concepts LLC’s holdings in Equifax were worth $1,263,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Cetera Advisors LLC lifted its position in shares of Equifax by 75.5% during the first quarter. Cetera Advisors LLC now owns 2,269 shares of the credit services provider’s stock worth $607,000 after purchasing an additional 976 shares in the last quarter. SG Americas Securities LLC increased its stake in shares of Equifax by 22.0% in the 2nd quarter. SG Americas Securities LLC now owns 23,593 shares of the credit services provider’s stock valued at $5,720,000 after buying an additional 4,250 shares during the period. Czech National Bank lifted its stake in shares of Equifax by 8.6% during the second quarter. Czech National Bank now owns 23,555 shares of the credit services provider’s stock valued at $5,711,000 after acquiring an additional 1,861 shares during the period. Sequoia Financial Advisors LLC boosted its holdings in Equifax by 42.5% in the second quarter. Sequoia Financial Advisors LLC now owns 1,079 shares of the credit services provider’s stock valued at $262,000 after acquiring an additional 322 shares during the last quarter. Finally, Wedmont Private Capital increased its position in Equifax by 10.8% in the second quarter. Wedmont Private Capital now owns 2,411 shares of the credit services provider’s stock worth $622,000 after purchasing an additional 235 shares during the period. Institutional investors and hedge funds own 96.20% of the company’s stock.

Equifax Price Performance

Shares of EFX opened at $266.82 on Monday. The company has a 50 day moving average of $270.48 and a 200-day moving average of $269.33. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.96. The stock has a market capitalization of $33.07 billion, a P/E ratio of 59.29, a P/E/G ratio of 3.27 and a beta of 1.57. Equifax Inc. has a twelve month low of $213.02 and a twelve month high of $309.63.

Equifax (NYSE:EFX) last released its earnings results on Wednesday, October 16th. The credit services provider reported $1.85 earnings per share for the quarter, beating analysts’ consensus estimates of $1.84 by $0.01. Equifax had a net margin of 10.07% and a return on equity of 18.56%. The business had revenue of $1.44 billion during the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter last year, the firm earned $1.76 earnings per share. The firm’s revenue for the quarter was up 9.3% compared to the same quarter last year. As a group, equities research analysts forecast that Equifax Inc. will post 7.28 EPS for the current fiscal year.

Equifax Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, December 13th. Investors of record on Friday, November 22nd will be given a dividend of $0.39 per share. The ex-dividend date is Friday, November 22nd. This represents a $1.56 annualized dividend and a yield of 0.58%. Equifax’s dividend payout ratio (DPR) is presently 34.67%.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on EFX. Needham & Company LLC reaffirmed a “buy” rating and issued a $350.00 target price on shares of Equifax in a research note on Monday, October 28th. Morgan Stanley lifted their target price on shares of Equifax from $250.00 to $271.00 and gave the stock an “equal weight” rating in a report on Thursday, September 12th. Stifel Nicolaus reduced their price target on Equifax from $305.00 to $284.00 and set a “buy” rating on the stock in a research report on Wednesday, November 20th. BNP Paribas upgraded Equifax from an “underperform” rating to a “neutral” rating and set a $310.00 price objective for the company in a report on Thursday, September 19th. Finally, Wells Fargo & Company restated a “buy” rating on shares of Equifax in a report on Friday, October 18th. Four research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $308.94.

Insider Buying and Selling at Equifax

In related news, EVP John J. Kelley III sold 1,000 shares of Equifax stock in a transaction dated Friday, October 25th. The stock was sold at an average price of $272.92, for a total transaction of $272,920.00. Following the completion of the transaction, the executive vice president now owns 11,269 shares in the company, valued at approximately $3,075,535.48. This trade represents a 8.15 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Lisa M. Nelson sold 551 shares of the business’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $260.39, for a total value of $143,474.89. Following the transaction, the executive vice president now directly owns 11,697 shares in the company, valued at approximately $3,045,781.83. This trade represents a 4.50 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 59,855 shares of company stock worth $16,187,044 over the last ninety days. 1.57% of the stock is currently owned by corporate insiders.

Equifax Profile

Equifax Inc operates as a data, analytics, and technology company. The company operates through three segments: Workforce Solutions, U.S. Information Solutions (USIS), and International. The Workforce Solutions segment offers services that enables customers to verify income, employment, educational history, criminal justice data, healthcare professional licensure, and sanctions of people in the United States; and employer customers with services that assist them in complying with and automating payroll-related and human resource management processes throughout the entire cycle of the employment relationship.